Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

filgrastim

filgrastim
Brand names: Neupogen and biosimilars, Releuko
Form Strength
INJECTION, INJECTABLE 300 mcg; 480 mcg
SOLUTION, INJECTABLE 300 mcg/ 0.5 mL; 480 mcg/1.6 mL

VIEW MORE Hematopoietic Agents
CLASS
201600

Additional Information:

Releuko (filgrastim-ayow) is the inpatient preferred filgrastim product in Legacy Hospitals.

Nivestym (filgrastim- aafi) may be used for pediatric doses, since this is supplied in a vial rather than prefilled syringe (conducive to pediatric dosing).

 


Last updated: Jul. 1, 2025







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.